About
Corbus Pharmaceuticals is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. by leveraging its industry leading pipeline of endocannabinoid system-targeting drug candidates.